Osteoporosis : Prophylaxis, diagnostics and therapy according to the guidelines;Osteoporose : Leitliniengerechte prophylaxe, diagnostik und therapie

Internist

Volumn 52, Issue 7, 2011, Pages 843-854

  Lange, U ^a   Muller Ladner U ^a   Pfeilschifter, J ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b ALFRIED KRUPP KRANKENHAUS   (Germany)

Author keywords

Bone mineral density; Fractures; Guideline; Osteoporosis; Osteoporosis medication

Indexed keywords

CALCIUM; VITAMIN D;

FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; MUSCLE FUNCTION; OSTEOPOROSIS; PRACTICE GUIDELINE; PROPHYLAXIS; QUALITY OF LIFE; REVIEW; VERTEBRA FRACTURE; VITAMIN SUPPLEMENTATION;

ADULT; AGED; BONE DENSITY CONSERVATION AGENTS; CALCIUM; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; SPINAL FRACTURES; VITAMIN D;

EID: 79959728165     PISSN: 00209554     EISSN: 14321289     Source Type: Journal    
DOI: 10.1007/s00108-011-2851-2     Document Type: Review

References (19)

1. Bianchi G, Sambrook P (2008) Oral nitrogen-containing bisphosphonates: a systemic review of randomized clinical trials and vertebral fractures. Curr Med Res Opin 24:2669-2677
2. Blake GM, Fogelman I (2007) Role of dual-energy x-ray absorptiometry in the diagnosis and treatment of osteoporosis. J Clin Densitom 10:102-110 (Pubitemid 46199277)
3. Cummings SR, San Martin J, Mc-Clung MR et al (2009) Freedom trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756-765
4. Curtis JR, Westfall AO, Cheng H et al (2008) Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday. Osteoporos Int 19:1613-1620
5. Dachverband Osteologie e. V. (2009) DVO-Leitlinie 2009 zur Prophylaxe, Diagnostik und Therapie der Osteoporose bei Erwachsenen. Osteologie 18:304-328, www.dv-osteologie.org/dvo-leitlinien/dvo-leitlinie-2009
6. Felsenberg D, Dietzel R, Begerow B et al. (2008) Kurzfassung "Leitlinie Physiotherapie und Bewegungstherapie bei Osteoporose". www.dv-osteologie.org/uploads/leitlinien/Kurzfassung- Physiotherapie-Leitlinie. pdf
7. Gallagher A, Rietbrock S, Olson M et al (2008) Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res 23:1569-1575
8. Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:10805-10865
9. Kanis JA, Johansson H, Oden A et al (2004) A metaanalysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893-899 (Pubitemid 41103445)
10. Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375-382 (Pubitemid 38953182)
11. Orstavik RE, Haugeberg G, Mowinckel P et al (2004) Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls. Arch Intern Med 164:420-425 (Pubitemid 38240706)
12. Saag K, Shane E, Boonen S et al (2007) Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 357:2028-2039 (Pubitemid 350106710)
13. Seeman E (2007) Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy? Bone 41:308-317
14. Smith MR, Egerdie B, Hernández Toriz N et al (2009) Denosumab halt prostate cancer study group. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 361:745-755
15. Steinbuch M, Youket TE, Cohen S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 15:323-28 (Pubitemid 38543952)
16. Steingrimsdottir L, Gunnarsson O, Indridason OS et al (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency and calcium intake. JAMA 294:2336-2341 (Pubitemid 41607410)
17. Tervo T, Nordström P, Neovius M et al (2008) Constant adaptation of bone to current physical activity level in men: A 12-year longitudinal study. J Clin Endocrinol Metab 93:4873-4879
18. van Staa TP, Geusens P, Bijlsma JW et al (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54:3104-3112 (Pubitemid 44622079)
19. van Staa TP, Leufkens HGM, Abenhaim L et al (2000) Use of oral corticosteroids and risk of fracture. J Bone Min Res 15:993-1000 (Pubitemid 30350061)